Oracle ORCL Q4 2026 Earnings Call Transcript

Oracle reported a record Q4 with revenue of $19.2B, up 21%, cloud infrastructure revenue up 93%, and non-GAAP EPS up 24% to $2.11. Full-year revenue surpassed $67B for the first time, RPO jumped 363% to $638B, and cash flow from operations rose 54% to $32B, underscoring very strong demand for AI and cloud services. Management also guided FY2027 revenue growth to 34% in constant currency and EPS to $8.05, while outlining a $70B net CapEx plan and $40B in planned financing.

Analysis

Oracle just converted a narrative problem into a balance-sheet problem: the business is now constrained more by financing and build cadence than by demand. That is constructive for revenue visibility, but it also shifts the equity story from 'software multiple' toward 'infrastructure utility with software attach,' which should compress valuation dispersion versus pure SaaS peers while expanding the market’s willingness to underwrite higher absolute earnings power.

The hidden winner here is not just Oracle; it is the upstream ecosystem that can sell into a faster-than-expected buildout without taking balance-sheet risk. Power equipment, networking, cooling, and certain component suppliers gain from a multi-quarter procurement wave, but the real second-order effect is tighter allocation across the AI hardware supply chain as Oracle and peers lock capacity earlier. That tends to support pricing for scarce inputs even if end-demand becomes more competitive, while making project timing more important than unit volume for near-term margin surprises.

The main risk is that the market may extrapolate contracted demand into near-term monetization too aggressively. If delivery slips by even one quarter, the stock can de-rate hard because the multiple is now implicitly underwriting flawless conversion of RPO into revenue and cash flow; any mismatch between prepayments, capex, and recognized revenue would create headline growth but weaker free-cash-flow optics. Over the next 3-6 months, watch for whether incremental contracts remain prepaid/bring-your-own-hardware or shift back toward Oracle-funded capex, because that changes both dilution risk and the equity’s effective leverage profile.

Contrarian take: the bullish case is probably real, but consensus is underestimating how much of the upside is already in the order book. The better trade is not a blanket long on momentum alone; it is a relative-value expression versus expensive AI infrastructure enablers that lack Oracle’s contracted visibility. If execution stays clean into the next two print cycles, the market may reward ORCL as a cash-flow compounding infrastructure platform rather than a speculative AI winner.

Key Decisions for Investors

• Long ORCL on a 3-6 month horizon, but size it as a quality-growth/infra hybrid, not a pure software multiple; target is continued re-rating if Q1 and Q2 show on-time megawatt delivery. Risk: any capex/delivery slippage can compress the stock 10-15% quickly.
• Pair trade: long ORCL / short a basket of higher-multiple AI infra beneficiaries with weaker contracted visibility (e.g., NVDA on the margin, or a market-neutral basket versus AI cloud proxies) over 1-2 quarters. Thesis: Oracle’s contracted backlog lowers execution risk relative to names trading primarily on narrative.
• Buy ORCL downside protection via 2-4 month puts if the stock gaps on the print and implied vol remains muted. The catalyst path is asymmetric: a single guidance/delivery miss matters more than another good quarter because expectations are now elevated.
• If you want upstream exposure, look at select power/cooling/networking suppliers on pullbacks, but only those with order-book visibility and limited customer concentration risk over 6-12 months. The second-order winner is the pick-and-shovel layer, not generic semiconductor beta.
• Avoid chasing the move in the broad AI trade purely on Oracle’s print; instead wait for evidence that prepaid/bring-your-own-hardware mix stays high in the next filing. If that mix deteriorates, equity funding needs rise and the market may punish the stock despite strong top-line growth.